Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives

Area of Science:

• Oncology
• Pathology

Background:

• SMARCA4-deficient undifferentiated tumor is a newly identified, aggressive thoracic malignancy.
• Previously considered a sarcoma subtype, it's now classified as an epithelial malignancy by WHO.
• This rare tumor presents a poor prognosis, necessitating further investigation.

Approach:

• This review synthesizes current literature on thoracic SMARCA4-deficient undifferentiated tumors.
• It covers clinical features, diagnostic methods, and therapeutic strategies.
• Future research directions are also discussed.

Key Points:

• SMARCA4-deficient undifferentiated tumors exhibit an undifferentiated or rhabdoid phenotype.
• High aggressiveness and rarity complicate treatment planning.
• Accurate diagnosis and understanding tumor biology are crucial.

Conclusions:

• Optimal treatment strategies for this rare thoracic malignancy remain elusive.
• Further research is essential to improve clinical outcomes.
• Understanding SMARCA4-deficient tumors is critical for advancing thoracic oncology.